These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 17682206)
41. [Autoradiographic findings in correlation to in-vitro sensitivity of breast carcinoma]. Nord D; Bastert G; Schmidt-Matthiesen H; Gerner R; Michel RT Arch Gynakol; 1975 Nov; 219(1-4):168-70. PubMed ID: 1243273 [No Abstract] [Full Text] [Related]
42. Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients. Nagashima T; Sakakibara M; Nakamura R; Arai M; Kadowaki M; Kazama T; Nakatani Y; Koda K; Miyazaki M Eur J Radiol; 2006 Nov; 60(2):270-4. PubMed ID: 16926079 [TBL] [Abstract][Full Text] [Related]
43. Assessment of breast cancer response to neoadjuvant chemotherapy: is volumetric MRI a reliable tool? Lorenzon M; Zuiani C; Londero V; Linda A; Furlan A; Bazzocchi M Eur J Radiol; 2009 Jul; 71(1):82-8. PubMed ID: 18472240 [TBL] [Abstract][Full Text] [Related]
44. [Application of dynamic contrast enhancement MRI and post-processing technique for diagnosis of breast cancer]. Peng KQ; Huang ZL; Xie CM; Chen L; Ouyang Y; Zheng QS; Zhang Y; He HQ; Wu PH Ai Zheng; 2009 May; 28(5):549-54. PubMed ID: 19624888 [TBL] [Abstract][Full Text] [Related]
45. [Dynamic enhanced MRI and chemosensitivity in breast cancer]. Nagashima T; Sakakibara M; Miyazaki M; Kazama T Nihon Rinsho; 2007 Jun; 65 Suppl 6():530-4. PubMed ID: 17682206 [No Abstract] [Full Text] [Related]
46. [MR imaging in the management of patients with breast cancer]. Yuen S; Goto M; Nishimura T Nihon Rinsho; 2007 Jun; 65 Suppl 6():357-62. PubMed ID: 17679208 [No Abstract] [Full Text] [Related]
47. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Knopp MV; Brix G; Junkermann HJ; Sinn HP Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):633-58. PubMed ID: 7489314 [TBL] [Abstract][Full Text] [Related]
48. MRI in the detection and management of breast cancer. Padhani AR; Ah-See ML; Makris A Expert Rev Anticancer Ther; 2005 Apr; 5(2):239-52. PubMed ID: 15877522 [TBL] [Abstract][Full Text] [Related]
49. The specificity of contrast-enhanced breast MR imaging. Piccoli CW Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):557-71. PubMed ID: 7489308 [TBL] [Abstract][Full Text] [Related]
50. [Prediction of the aggressiveness of breast cancer by MRI]. Kimijima I Nihon Rinsho; 2007 Jun; 65 Suppl 6():367-72. PubMed ID: 17682180 [No Abstract] [Full Text] [Related]
51. Dynamic contrast-enhanced breast MR imaging. Moon M; Cornfeld D; Weinreb J Magn Reson Imaging Clin N Am; 2009 May; 17(2):351-62. PubMed ID: 19406363 [TBL] [Abstract][Full Text] [Related]
52. Diagnostic breast MR imaging: current status and future directions. Morris EA Radiol Clin North Am; 2007 Sep; 45(5):863-80, vii. PubMed ID: 17888774 [TBL] [Abstract][Full Text] [Related]
53. Molecular targets in breast cancer: current status and future directions. Cristofanilli M; Hortobagyi GN Endocr Relat Cancer; 2002 Dec; 9(4):249-66. PubMed ID: 12542402 [TBL] [Abstract][Full Text] [Related]